Mark J. Mulligan - Researcher Profile

Publications

2 shown

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh , Robert W. Frenck , Ann R. Falsey +22 more

The safety and immunogenicity data from this U.S. phase 1 trial of two vaccine candidates in younger and older adults, added to earlier interim safety and immunogenicity data re...

2020 New England Journal of Medicine 2665 citations

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan , Kirsten E. Lyke , Nicholas Kitchin +22 more

2020 Nature 1546 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 4,211
Institution: NYU Langone Health

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-7262-9746

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.